Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sodium chloride + urea is a topical combination therapy used as a moisturizing and keratolytic agent for the treatment of dry and scaly skin conditions, including atopic dermatitis, ichthyosis, and psoriasis. Urea serves as a humectant that increases the water-binding capacity of the stratum corneum and, in higher concentrations, acts as a keratolytic by solubilizing keratin. The addition of sodium chloride is intended to synergistically enhance skin hydration and normalize the physical properties of the skin barrier, such as electrical impedance. This combination is commonly marketed under the brand name Calmurid and is typically formulated as a cream or lotion for twice-daily application.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on sodium chloride + urea.